These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 11306463)

  • 1. A cyclin D1/cyclin-dependent kinase 4 binding site within the C domain of the retinoblastoma protein.
    Pan W; Cox S; Hoess RH; Grafström RH
    Cancer Res; 2001 Apr; 61(7):2885-91. PubMed ID: 11306463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docking-dependent regulation of the Rb tumor suppressor protein by Cdk4.
    Wallace M; Ball KL
    Mol Cell Biol; 2004 Jun; 24(12):5606-19. PubMed ID: 15169919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
    Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S
    Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The amino terminus of the retinoblastoma (Rb) protein associates with a cyclin-dependent kinase-like kinase via Rb amino acids required for growth suppression.
    Sterner JM; Tao Y; Kennett SB; Kim HG; Horowitz JM
    Cell Growth Differ; 1996 Jan; 7(1):53-64. PubMed ID: 8788033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical characterizations reveal different properties between CDK4/cyclin D1 and CDK2/cyclin A.
    Kim DM; Yang K; Yang BS
    Exp Mol Med; 2003 Oct; 35(5):421-30. PubMed ID: 14646596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of retinoblastoma protein phosphorylation by myogenesis-induced changes in the subunit composition of the cyclin-dependent kinase 4 complex.
    Wang J; Walsh K
    Cell Growth Differ; 1996 Nov; 7(11):1471-8. PubMed ID: 8930396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining the substrate specificity of cdk4 kinase-cyclin D1 complex.
    Grafstrom RH; Pan W; Hoess RH
    Carcinogenesis; 1999 Feb; 20(2):193-8. PubMed ID: 10069453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptotic and mitogenic stimuli inactivate Rb by differential utilization of p38 and cyclin-dependent kinases.
    Nath N; Wang S; Betts V; Knudsen E; Chellappan S
    Oncogene; 2003 Sep; 22(38):5986-94. PubMed ID: 12955077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferences for phosphorylation sites in the retinoblastoma protein of D-type cyclin-dependent kinases, Cdk4 and Cdk6, in vitro.
    Takaki T; Fukasawa K; Suzuki-Takahashi I; Semba K; Kitagawa M; Taya Y; Hirai H
    J Biochem; 2005 Mar; 137(3):381-6. PubMed ID: 15809340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining the minimal portion of the retinoblastoma protein that serves as an efficient substrate for cdk4 kinase/cyclin D1 complex.
    Pan W; Sun T; Hoess R; Grafstrom R
    Carcinogenesis; 1998 May; 19(5):765-9. PubMed ID: 9635861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of growth suppression by p107 via direct phosphorylation by cyclin D1/cyclin-dependent kinase 4.
    Leng X; Noble M; Adams PD; Qin J; Harper JW
    Mol Cell Biol; 2002 Apr; 22(7):2242-54. PubMed ID: 11884610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct inhibition of G(1) cdk kinase activity by MyoD promotes myoblast cell cycle withdrawal and terminal differentiation.
    Zhang JM; Zhao X; Wei Q; Paterson BM
    EMBO J; 1999 Dec; 18(24):6983-93. PubMed ID: 10601020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coupling of the cell cycle and myogenesis through the cyclin D1-dependent interaction of MyoD with cdk4.
    Zhang JM; Wei Q; Zhao X; Paterson BM
    EMBO J; 1999 Feb; 18(4):926-33. PubMed ID: 10022835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
    Serrano M; Hannon GJ; Beach D
    Nature; 1993 Dec; 366(6456):704-7. PubMed ID: 8259215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of DNA polymerase alpha activity by cdk2-phosphorylated Rb protein.
    Takemura M; Yamamoto T; Kitagawa M; Taya Y; Akiyama T; Asahara H; Linn S; Suzuki S; Tamai K; Yoshida S
    Biochem Biophys Res Commun; 2001 Apr; 282(4):984-90. PubMed ID: 11352649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cyclin box and C-terminus of cyclins A and E specify CDK activation and substrate specificity.
    Horton LE; Templeton DJ
    Oncogene; 1997 Jan; 14(4):491-8. PubMed ID: 9053846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of cyclin D1/CDK4 and pRb mediated by PI3K/AKT pathway activation in Pb2+ -induced neuronal death in cultured hippocampal neurons.
    Li C; Xing T; Tang M; Yong W; Yan D; Deng H; Wang H; Wang M; Chen J; Ruan D
    Toxicol Appl Pharmacol; 2008 Jun; 229(3):351-61. PubMed ID: 18353414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of cyclin D1-Cdk4 and Cdk4-directed phosphorylation of RB protein in diabetic mesangial hypertrophy.
    Féliers D; Frank MA; Riley DJ
    Diabetes; 2002 Nov; 51(11):3290-9. PubMed ID: 12401721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1 suppresses retinoblastoma protein-mediated inhibition of TAFII250 kinase activity.
    Siegert JL; Rushton JJ; Sellers WR; Kaelin WG; Robbins PD
    Oncogene; 2000 Nov; 19(50):5703-11. PubMed ID: 11126356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible regulation of the retinoblastoma protein/E2F-1 pathway during "reverse cardiac remodelling" after ventricular unloading.
    Wohlschlaeger J; Schmitz KJ; Takeda A; Takeda N; Vahlhaus C; Stypmann J; Schmid C; Baba HA
    J Heart Lung Transplant; 2010 Jan; 29(1):117-24. PubMed ID: 20123249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.